Study of the Safety and Efficacy of REGN727/SAR236553 in Patients With HeFH Hypercholesterolemia
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of REGN727/SAR236553 in
participants diagnosed with heterozygous familial hypercholesterolemia (heFH)